These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1748155

  • 21. Antihypertensive activity of the novel, nonpeptide angiotensin II receptor antagonists BIBS 39 and BIBS 222 in conscious renal hypertensive rats.
    Zhang J, Van Meel JC, Van Zwieten PA.
    Pharmacology; 1993 May; 46(5):241-7. PubMed ID: 8488169
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
    Eberhardt RT, Kevak RM, Kang PM, Frishman WH.
    J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
    [Abstract] [Full Text] [Related]

  • 23. Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan.
    Abdelrahman A, Pang CC.
    Can J Physiol Pharmacol; 1992 May; 70(5):716-9. PubMed ID: 1423014
    [Abstract] [Full Text] [Related]

  • 24. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
    Keiser JA, Bjork FA, Hodges JC, Taylor DG.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1154-60. PubMed ID: 1527720
    [Abstract] [Full Text] [Related]

  • 25. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [Abstract] [Full Text] [Related]

  • 26. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE, Cohen RB, Skwish S, Delaney CL, Serafino RP, Poss MA, Gu Z, Ryono DE, Moreland S, Powell JR.
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [Abstract] [Full Text] [Related]

  • 27. Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs.
    Richard V, Berdeaux A, Giudicelli JF.
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):52-7. PubMed ID: 7690096
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L, de Gasparo M, Bühlmayer P, Whitebread S, Ramjoué HP, Wood J.
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [Abstract] [Full Text] [Related]

  • 29. In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.
    Kivlighn SD, Zingaro GJ, Gabel RA, Broten TP, Schorn TW, Schaffer LW, Naylor EM, Chakravarty PK, Patchett AA, Greenlee WJ.
    Am J Hypertens; 1995 Jan; 8(1):58-66. PubMed ID: 7734099
    [Abstract] [Full Text] [Related]

  • 30. Effect of angiotensin II antagonism on canine renal sympathetic nerve function.
    Wong PC, Hart SD, Timmermans PB.
    Hypertension; 1991 Jun; 17(6 Pt 2):1127-34. PubMed ID: 2045159
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.
    Lacour C, Roccon A, Cazaubon C, Segondy D, Nisato D.
    J Hypertens; 1993 Nov; 11(11):1187-94. PubMed ID: 8301099
    [Abstract] [Full Text] [Related]

  • 32. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
    Duan J, Jaramillo J, Jung GL, McLeod AL, Fernandes BH, Mathis D.
    Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944
    [Abstract] [Full Text] [Related]

  • 33. Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.
    Tofovic SP, Pong AS, Jackson EK.
    Hypertension; 1991 Dec; 18(6):774-82. PubMed ID: 1743758
    [Abstract] [Full Text] [Related]

  • 34. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ, Tree M, Lever AF, Reid JL.
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [Abstract] [Full Text] [Related]

  • 35. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR, Lo MW, Christ DD, Chiou R, Furtek CI, Amit O, Carides A, Biollaz J, Piguet V, Nussberger J, Brunner HR.
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [Abstract] [Full Text] [Related]

  • 36. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O, Kushida H, Kunihara M.
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
    Widdop RE, Gardiner SM, Kemp PA, Bennett T.
    Br J Pharmacol; 1992 Nov; 107(3):873-80. PubMed ID: 1472980
    [Abstract] [Full Text] [Related]

  • 38. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system.
    Macari D, Whitebread S, Cumin F, De Gasparo M, Levens N.
    Eur J Pharmacol; 1994 Jun 23; 259(1):27-36. PubMed ID: 7957590
    [Abstract] [Full Text] [Related]

  • 39. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.
    Batin P, Gardiner SM, Compton AM, Kemp PA, Bennett T.
    Br J Pharmacol; 1991 Jun 23; 103(2):1585-91. PubMed ID: 1884112
    [Abstract] [Full Text] [Related]

  • 40. Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog.
    Chan DP, Sandok EK, Aarhus LL, Heublein DM, Burnett JC.
    Am J Hypertens; 1992 Jun 23; 5(6 Pt 1):354-60. PubMed ID: 1524759
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.